Address
Sylviusweg 71
2333 BE Leiden
Zuid Holland
The Netherlands
Contact
Steven Erpelinck+313162395637
steven.erpelinck@tno.nl
Website
I-screen
96 well screening platform for antimicrobial/fungal drug candidates
Predictive data regarding gut health effects
Technology:
Microorganisms:
Application:
Development stage:
- Antimicrobial compound/strategy
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Fungi
- Viruses
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Research
- Development
- Validation
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Institute
- Company
- Academia
- NGO
- Government
Partnering:
- License
- Outsource
- Sell
- Co-develop
- Joint Venture
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- BSI
- GII
- CNSI
- STI
- RTI
- SSTI
- IAI
- SSI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
Fee for service plus collaboration via public-private partnership projects (TNO will co-fund these projects)
TNO is an independent research and technology Institute
u-dosing/tracer AMS generating early human PK, metabolism and mass balance data of antimicrobial/fungal drug candidates
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!